Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown250%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
completed

COVID-19 (SARS-CoV-2) in Urine and Semen

NCT04446169
unknown

Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity

NCT03486639
unknownnot_applicable

Prostate Cancer Screening Among Men With High Risk Genetic Predisposition

NCT02053805
completed

Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

NCT00316732

Clinical Trials (4)

Showing 4 of 4 trials
NCT04446169

COVID-19 (SARS-CoV-2) in Urine and Semen

Completed
NCT03486639

Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity

Unknown
NCT02053805Not Applicable

Prostate Cancer Screening Among Men With High Risk Genetic Predisposition

Unknown
NCT00316732

Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4